Physician profile
Thomas Vacek
NPI 1154681989
$22,158.55
in general payments reported to CMS, 2019-2025
31 companies · $350 in 2025
The $350 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $894 · 2021: $585 · 2022: $16K · 2023: $3,993 · 2024: $143 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,581 · Travel and Lodging: $1,904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,581.06 |
| Travel and Lodging | $1,904.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,635.41 | 2021-2025 | Hawkone, Micra, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $4,554.72 | 2019-2023 | Optis, Supera, Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,072.46 | 2020-2025 | Lifevest |
| Penumbra, INC. | $2,634.82 | 2021-2025 | Ruby Coil |
| Cardiovascular Systems INC. | $1,625.51 | 2022-2023 | Diamondback Coronary |
| Bard Peripheral Vascular, INC. | $435.86 | 2020 | |
| Novartis Pharmaceuticals Corporation | $408.77 | 2020-2023 | |
| Boston Scientific Corporation | $367.98 | 2019-2025 | Ekosonic |
| Janssen Pharmaceuticals, INC | $354.81 | 2020-2023 | Xarelto |
| Abiomed | $301.85 | 2022-2025 | Impella |
| Astrazeneca Pharmaceuticals Lp | $287.15 | 2020-2023 | Farxiga |
| Merck Sharp & Dohme LLC | $262.18 | 2021-2023 | Verquvo |
| Shockwave Medical, INC | $176.82 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $169.13 | 2021-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $158.52 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.76 | 2020-2023 | Jardiance |
| Amgen INC. | $96.84 | 2020-2023 | Repatha |
| Irhythm Technologies, INC. | $91.52 | 2020 | |
| Tactile Systems Technology INC | $56.17 | 2022 | |
| Philips North America LLC | $53.31 | 2024-2025 | Extended Holter, (Ck6) Holter |
| Terumo Medical Corporation | $42.72 | 2020-2021 | |
| Cordis US Corp. | $38.00 | 2023 | Vista Brite Tip, Adroit |
| Teleflex LLC | $32.22 | 2023-2025 | Guardian, Trapliner |
| Daiichi Sankyo INC. | $27.80 | 2023 | Injectafer |
| Alnylam Pharmaceuticals INC. | $20.32 | 2023 | Onpattro |
| Esperion Therapeutics, INC. | $19.83 | 2022 | |
| Pfizer INC. | $18.54 | 2022 | |
| Novo Nordisk INC | $17.67 | 2023 | Ozempic, Rybelsus |
| Xeris Pharmaceuticals, INC. | $16.72 | 2021 | |
| Zoll Circulation INC | $14.80 | 2025 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Lantheus Medical Imaging, INC. | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Vacek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.